EX-99.1 2 ex_828374.htm EXHIBIT 99.1 ex_828374.htm
 

Exhibit 99.1

logo01.jpg

FOR IMMEDIATE RELEASE

 

SUPERIOR GROUP OF COMPANIES REPORTS SECOND QUARTER 2025 RESULTS

 

– Total net sales of $144.0 million, up 9% over $131.7 million in prior year second quarter
– Net income of $1.6 million, up from $0.6 million in prior year second quarter 
– EBITDA of $6.1 million, up 9% over $5.6 million in prior year second quarter
– Continued to execute on stock repurchase plan 
– Board of Directors approves $0.14 per share quarterly dividend –

 

ST. PETERSBURG, Fla., August 5, 2025 – Superior Group of Companies, Inc. (NASDAQ: SGC) (the “Company”), today announced its second quarter 2025 results.

 

“We were able to grow revenue 9% over the prior year, led by Branded Products sales climbing a very healthy 14%, resulting in strong sequential improvement from the first quarter,” said Michael Benstock, Chief Executive Officer. “We are experiencing modest improvement in client sentiment and we will continue to leverage our diverse sourcing channels and marketing strategies to make the most of market conditions. With our strong balance sheet and cost actions taken during the year, we’re able to navigate changing market conditions, invest for future growth and return capital to shareholders whenever possible. In addition to our consistent dividend, during the quarter we also continued to repurchase shares which we consider a compelling value.”

 

Second Quarter Results

 

For the second quarter ended June 30, 2025, net sales were $144.0 million, up from second quarter 2024 net sales of $131.7 million. Pretax earnings of $1.8 million were up from $0.7 million in the second quarter of 2024. Net earnings of $1.6 million or $0.10 per diluted share were up from net income of $0.6 million or $0.04 per diluted share for the second quarter of 2024.

 

Second Quarter 2025 Dividend

 

The Board of Directors declared a quarterly dividend of $0.14 per share, payable August 29, 2025 to shareholders of record as of August 18, 2025.

 

Share Repurchase Update

 

The Company allocated $4.0 million to repurchasing approximately 390,000 shares during the second quarter, resulting in $12.3 million remaining under its existing repurchase authorization at quarter end.

 

2025 Full-Year Outlook

 

The Company is maintaining its full-year revenue outlook range of $550 million to $575 million.

 

1

 

Webcast and Conference Call

 

The Company will host a webcast and conference call at 5:00 pm Eastern Time today. The live webcast and archived replay can be accessed in the investor relations section of the Company's website at https://ir.superiorgroupofcompanies.com/Presentations. Interested individuals may also join the teleconference by dialing 1-844-861-5505 for U.S. dialers and 1-412-317-6586 for International dialers. The Canadian Toll-Free number is 1-866-605-3852. Please ask to be joined to the Superior Group of Companies call. A telephone replay of the teleconference will be available through August 19, 2025. To access the replay, dial 1-877-344-7529 in the United States or 1-412-317-0088 from international locations. Canadian dialers can access the replay at 855-669-9658. Please reference conference number 7254182 for replay access.

 

The Company’s website at https://ir.superiorgroupofcompanies.com/Presentations will also contain an updated investor presentation.

 

Disclosure Regarding Forward Looking Statements

 

Certain matters discussed in this press release are forward-looking statements intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements can generally be identified by use of the words may, will, should, could, expect,” “anticipate, estimate, believe, intend, project, potential, or plan or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements in this press release may include, without limitation: (1) projections of revenue, income, and other items relating to our financial position and results of operations, including short term and long term plans for cash, (2) statements of our plans, objectives, strategies, goals and intentions, (3) statements regarding the capabilities, capacities, market position and expected development of our business operations and (4) statements of expected industry and general economic trends.

 

Such forward-looking statements are subject to certain risks and uncertainties that may materially adversely affect the anticipated results. Such risks and uncertainties include, but are not limited to, the following: the impact of competition; the effect of existing and/or new or expanded tariffs, uncertainties related to supply disruptions, inflationary environment (including with respect to the cost of finished goods and raw materials and shipping costs), employment levels (including labor shortages), and general economic and political conditions in the areas of the world in which the Company operates or from which it sources its supplies or the areas of the United States of America (U.S. or United States) in which the Companys customers are located; changes in the healthcare, retail chain, food service, transportation and other industries where uniforms and service apparel are worn; our ability to identify suitable acquisition targets, discover liabilities associated with such businesses during the diligence process, successfully integrate any acquired businesses, or successfully manage our expanding operations; the price and availability of raw materials; attracting and retaining senior management and key personnel; the effect of the Companys previously disclosed material weakness in internal control over financial reporting; the Company may identify a material weakness in internal control in the future, which could result in us not preventing or detecting on a timely basis a material misstatement of the Companys financial statements and to maintain effective internal control over financial reporting; and other factors described in the Companys filings with the Securities and Exchange Commission, including those described in the Risk Factors section of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 and the Quarterly Report on Form 10-Q for the quarter ended June 30, 2025. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements made herein and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are only made as of the date of this press release and we disclaim any obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances, except as may be required by law.

 

About Superior Group of Companies, Inc. (SGC):

 

Established in 1920, Superior Group of Companies is comprised of three attractive business segments each serving large, fragmented and growing addressable markets. Across Healthcare Apparel, Branded Products and Contact Centers, each segment enables businesses to create extraordinary brand engagement experiences for their customers and employees. SGC’s commitment to service, quality, advanced technology, and omnichannel commerce provides unparalleled competitive advantages. We are committed to enhancing shareholder value by continuing to pursue a combination of organic growth and strategic acquisitions. For more information, visit www.superiorgroupofcompanies.com.

 

Investor Relations Contact:
Investors@Superiorgroupofcompanies.com

 

2

  

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except shares and per share data)

  

   

Three Months Ended June 30,

   

Six Months Ended June 30,

 
   

2025

   

2024

   

2025

   

2024

 

Net sales

  $ 144,045     $ 131,736     $ 281,142     $ 270,578  
                                 

Costs and expenses:

                               

Cost of goods sold

    88,719       80,981       175,375       164,506  

Selling and administrative expenses

    52,240       48,564       102,342       97,502  

Interest expense, net

    1,250       1,541       2,495       3,328  
      142,209       131,086       280,212       265,336  

Income before income tax expense

    1,836       650       930       5,242  

Income tax expense

    285       50       137       730  

Net income

  $ 1,551     $ 600     $ 793     $ 4,512  
                                 

Net income per share:

                               

Basic

  $ 0.10     $ 0.04     $ 0.05     $ 0.28  

Diluted

  $ 0.10     $ 0.04     $ 0.05     $ 0.27  
                                 

Weighted average shares outstanding during the period:

                               

Basic

    14,813,984       16,221,073       15,206,819       16,124,553  

Diluted

    15,101,942       16,769,297       15,573,692       16,611,375  
                                 

Cash dividends per common share

  $ 0.14     $ 0.14     $ 0.28     $ 0.28  

   

3

 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(In thousands, except shares and par value data)

 

   

June 30,

   

December 31,

 
   

2025

   

2024

 
   

(Unaudited)

         

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 21,026     $ 18,766  

Accounts receivable, net

    94,194       95,092  

Inventories

    106,597       96,675  

Contract assets

    53,762       51,688  

Prepaid expenses and other current assets

    10,003       10,831  

Total current assets

    285,582       273,052  

Property, plant and equipment, net

    40,221       41,879  

Operating lease right-of-use assets

    13,746       15,567  

Deferred tax asset

    13,830       13,835  

Intangible assets, net

    49,320       51,137  

Goodwill

    2,434       2,304  

Other assets

    18,123       17,360  

Total assets

  $ 423,256     $ 415,134  
                 

LIABILITIES AND SHAREHOLDERS’ EQUITY

               

Current liabilities:

               

Accounts payable

  $ 56,464     $ 50,942  

Other current liabilities

    41,610       44,367  

Current portion of long-term debt

    5,625       5,625  

Current portion of acquisition-related contingent liabilities

    1,600       814  

Total current liabilities

    105,299       101,748  

Long-term debt

    93,720       80,410  

Long-term pension liability

    13,514       13,315  

Long-term acquisition-related contingent liabilities

    668       935  

Long-term operating lease liabilities

    8,711       10,486  

Other long-term liabilities

    9,268       9,384  

Total liabilities

    231,180       216,278  

Shareholders’ equity:

               

Preferred stock, $.001 par value - authorized 300,000 shares (none issued)

    -       -  

Common stock, $.001 par value - authorized 50,000,000 shares, issued and outstanding 15,917,963 and 16,484,921 shares, respectively

    15       16  

Additional paid-in capital

    83,285       84,060  

Retained earnings

    112,017       120,139  

Accumulated other comprehensive loss, net of tax:

    (3,241 )     (5,359 )

Total shareholders’ equity

    192,076       198,856  

Total liabilities and shareholders’ equity

  $ 423,256     $ 415,134  

 

 

4

 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

 

   

Six Months Ended June 30,

 
   

2025

   

2024

 

CASH FLOWS FROM OPERATING ACTIVITIES

               

Net income

  $ 793     $ 4,512  

Adjustments to reconcile net income to net cash provided by operating activities:

               

Depreciation and amortization

    6,182       6,620  

Inventory write-downs

    1,042       888  

Credit loss expense

    2,100       (383 )

Share-based compensation expense

    2,561       1,620  

Change in fair value of acquisition-related contingent liabilities

    520       296  

Other, net

    182       775  

Changes in assets and liabilities, net of acquisition of a business:

               

Accounts receivable

    (569 )     10,578  

Contract assets

    (1,682 )     (4,526 )

Inventories

    (10,692 )     3,936  

Prepaid expenses and other current assets

    1,267       (1,309 )

Other assets

    (789 )     (761 )

Accounts payable and other current liabilities

    1,740       (6,424 )

Other long-term liabilities

    291       478  

Net cash provided by operating activities

    2,946       16,300  
                 

CASH FLOWS FROM INVESTING ACTIVITIES

               

Additions to property, plant and equipment

    (2,716 )     (1,974 )

Net cash used in investing activities

    (2,716 )     (1,974 )
                 

CASH FLOWS FROM FINANCING ACTIVITIES

               

Borrowings under revolving lines of credit

    57,000       10,000  

Payments under revolving lines of credit

    (41,000 )     (24,000 )

Payments of term loan

    (2,812 )     (1,875 )

Payment of cash dividends

    (4,515 )     (4,657 )

Payment of acquisition-related contingent liabilities

    -       (557 )

Proceeds received on exercise of stock options and payments for shares withheld for taxes

    189       1,076  

Common shares repurchased and retired

    (7,926 )     -  

Net cash provided by (used in) financing activities

    936       (20,013 )
                 

Effect of currency exchange rates on cash

    1,094       (835 )

Net increase in cash and cash equivalents

    2,260       (6,522 )

Cash and cash equivalents balance, beginning of period

    18,766       19,896  

Cash and cash equivalents balance, end of period

  $ 21,026     $ 13,374  

 

5

 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

NON-GAAP FINANCIAL MEASURES

(Unaudited)

(In thousands)

 

   

Three Months Ended June 30,

   

Six Months Ended June 30,

 
   

2025

   

2024

   

2025

   

2024

 

Net income

  $ 1,551     $ 600     $ 793     $ 4,512  

Interest expense, net

    1,250       1,541       2,495       3,328  

Income tax expense

    285       50       137       730  

Depreciation and amortization

    2,978       3,368       6,182       6,620  

EBITDA(1)

  $ 6,064     $ 5,559     $ 9,607     $ 15,190  

EBITDA margin(1)

    4.2 %     4.2 %     3.4 %     5.6 %

 

(1) EBITDA, which is a non-GAAP financial measure, is defined as net income excluding interest expense, net, income tax expense and depreciation and amortization expense. EBITDA margin is defined as EBITDA divided by net sales. The Company believes EBITDA is an important measure of operating performance because it allows management, investors and others to evaluate and compare the Company’s core operating results from period to period by removing (i) the impact of the Company’s capital structure (interest expense from outstanding debt), (ii) tax consequences and (iii) asset base (depreciation and amortization). The Company uses EBITDA internally to monitor operating results and to evaluate the performance of its business. In addition, the compensation committee has used EBITDA in evaluating certain components of executive compensation, including performance-based annual incentive programs. EBITDA is not a measure of financial performance under GAAP.  EBITDA should not be considered in isolation or as an alternative to net income, cash flows from operating activities or any other measure determined in accordance with GAAP. The items excluded to calculate EBITDA are significant components in understanding and assessing the Company’s results of operations. The Company’s EBITDA may not be comparable to a similarly titled measure of another company because other entities may not calculate EBITDA in the same manner.

 

6

 

SUPERIOR GROUP OF COMPANIES, INC. AND SUBSIDIARIES

SUPPLEMENTAL INFORMATION - REPORTABLE SEGMENTS

(Unaudited)

(In thousands)

 

   

Branded Products

   

Healthcare Apparel

   

Contact Centers

   

Intersegment Eliminations

   

Other

   

Total

 

For the Three Months Ended June 30, 2025:

                                               

Net sales

  $ 92,647     $ 28,253     $ 23,977     $ (832 )   $ -     $ 144,045  

Cost of goods sold

    59,631       18,237       11,364       (513 )     -       88,719  

Gross margin

    33,016       10,016       12,613       (319 )     -       55,326  

Selling and administrative expenses

    25,432       10,078       11,612       (319 )     5,437       52,240  

Depreciation and amortization

    1,395       854       639       -       90       2,978  

Segment EBITDA(1)

  $ 8,979     $ 792     $ 1,640     $ -     $ (5,347 )   $ 6,064  
                                                 
   

Branded Products

   

Healthcare Apparel

   

Contact Centers

   

Intersegment Eliminations

   

Other

   

Total

 

For the Three Months Ended June 30, 2024:

                                               

Net sales

  $ 81,296     $ 26,592     $ 24,832     $ (984 )   $ -     $ 131,736  

Cost of goods sold

    53,170       16,392       11,871       (452 )     -       80,981  

Gross margin

    28,126       10,200       12,961       (532 )     -       50,755  

Selling and administrative expenses

    22,969       9,879       10,533       (532 )     5,715       48,564  

Depreciation and amortization

    1,567       956       753       -       92       3,368  

Segment EBITDA(1)

  $ 6,724     $ 1,277     $ 3,181     $ -     $ (5,623 )   $ 5,559  
                                                 
    Branded Products     Healthcare Apparel     Contact Centers     Intersegment Eliminations     Other     Total  

For the Six Months Ended June 30, 2025:

                                               

Net sales

  $ 179,121     $ 55,516     $ 48,202     $ (1,697 )   $ -     $ 281,142  

Cost of goods sold

    118,418       35,367       22,608       (1,018 )     -       175,375  

Gross margin

    60,703       20,149       25,594       (679 )     -       105,767  

Selling and administrative expenses

    48,852       19,604       22,533       (679 )     12,032       102,342  

Depreciation and amortization

    2,875       1,766       1,361       -       180       6,182  

Segment EBITDA(1)

  $ 14,726     $ 2,311     $ 4,422     $ -     $ (11,852 )   $ 9,607  
                                                 
    Branded Products     Healthcare Apparel     Contact Centers     Intersegment Eliminations     Other     Total  

For the Six Months Ended June 30, 2024:

                                               

Net sales

  $ 168,364     $ 55,829     $ 48,384     $ (1,999 )   $ -     $ 270,578  

Cost of goods sold

    108,497       34,119       22,779       (889 )     -       164,506  

Gross margin

    59,867       21,710       25,605       (1,110 )     -       106,072  

Selling and administrative expenses

    46,263       19,691       20,954       (1,110 )     11,704       97,502  

Depreciation and amortization

    3,067       1,893       1,476       -       184       6,620  

Segment EBITDA(1)

  $ 16,671     $ 3,912     $ 6,127     $ -     $ (11,520 )   $ 15,190  

 

(1) Segment EBITDA is our primary measure of segment profitability under U.S. GAAP ASC 280 “Segment Reporting”. Amounts included in income before income tax expense and excluded from Segment EBITDA include: interest expense, net and depreciation and amortization expense. Total EBITDA is a non-GAAP financial measure. Please see reconciliation of Total EBITDA included in the Non-GAAP Financial Measures table above.

 

7